Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular carcinoma, Medicine, Cancer research, Sorafenib, Reactive oxygen species, and In vivo.
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma
LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2
Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation